Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae

被引:2
|
作者
Feng, Yan [1 ,2 ]
Fang, Qingqing [1 ,2 ,3 ]
Luo, Huan [2 ,4 ]
Li, Juan [1 ,2 ]
Yin, Xin [1 ,2 ]
Zong, Zhiyong [1 ,2 ,4 ,5 ]
机构
[1] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China
[2] State Key Lab Biotherapy, Div Infect Dis, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Gen Practice Ward, Int Med Ctr Ward,Gen Practice Med Ctr, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Ctr Pathogen Res, Chengdu, Peoples R China
[5] West China Hosp Huaxi, Ctr Infect Dis, Guoxuexiang 37, Chengdu 610041, Peoples R China
关键词
Phage therapy; Antimicrobial resistance; Carbapenem-resistant Klebsiella pneumoniae; Safety; BACTERIOPHAGE;
D O I
10.1016/j.ijantimicag.2024.107088
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
<bold>Objectives: </bold>Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a leading pathogen causing difficult-to-treat, healthcare-associated wound infections. Phages are an alternative approach against CRKP. This study established murine wound infection models with a CRKP clinical strain of sequence type 11 and capsular type KL64, which is the dominant type in China, carrying genes encoding KPC-2 and NDM-1 carbapenemases. <bold>Methods: </bold>A cocktail was made comprising three lytic phages of different viral families against the strain. The phage cocktail restricted bacterial growth for 10 hours in vitro. The efficacy and safety of the phage cocktail in treating a murine wound CRKP infection were then evaluated. Mice were randomly assigned into four groups (16 for each) comprising a phage treatment group, infected with bacteria and 30 minutes later with phages, and three control groups administered with PBS (negative control), bacteria (infection control), or phages (phage control) on the wound. Wound tissues were processed for counting bacterial loads on days 1, 3, and 7 post-infection and examined for histopathological change on days 3 and 7. Two remaining mice in each group were monitored for wound healing until day 14. <bold>Results: </bold>Compared with the infection control group, the wound bacterial load in the phage treatment group decreased by 4.95 x 10(2) CFU/g (> 100-fold; P < 0.05) at day 7 post-treatment, and wounds healed on day 10, as opposed to day 14 in the infection control group. No adverse events associated with phages were observed. <bold>Conclusion: </bold>The phage cocktail significantly reduced the wound bacterial load and promoted wound healing with good safety.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] The Mobilome of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates
    A. E. Alekseeva
    N. F. Brusnigina
    N. A. Gordinskaya
    Russian Journal of Genetics, 2020, 56 : 280 - 288
  • [42] Carbapenem-resistant Klebsiella pneumoniae with low chlorhexidine susceptibility
    Stein, Claudia
    Vincze, Szilvia
    Kipp, Frank
    Makarewicz, Oliwia
    Al Dahouk, Sascha
    Pletz, Mathias W.
    LANCET INFECTIOUS DISEASES, 2019, 19 (09): : 932 - 933
  • [43] Rapid Nanopore Assay for Carbapenem-Resistant Klebsiella pneumoniae
    Niu, Haofu
    Zhang, Weili
    Wei, Liangwan
    Liu, Meng
    Liu, Hao
    Zhao, Changjian
    Zhang, Peng
    Liao, Quanfeng
    Liu, Ya
    Yuan, Qingyue
    Wu, Siying
    Kang, Mei
    Geng, Jia
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [44] Changing epidemiology of carbapenem-resistant Enterobacteriaceae carriage during an outbreak of carbapenem-resistant Klebsiella pneumoniae
    Geffen, Y.
    Finkelstein, R.
    Oren, I.
    Shalaginov, R.
    Tavleva, I.
    Sprecher, H.
    JOURNAL OF HOSPITAL INFECTION, 2010, 76 (04) : 355 - 356
  • [45] Transmission of Carbapenem-Resistant Klebsiella Pneumoniae in US Hospitals
    Luterbach, Courtney L.
    Chen, Liang
    Komarow, Lauren
    Ostrowsky, Belinda
    Kaye, Keith S.
    Hanson, Blake
    Arias, Cesar A.
    Desai, Samit
    Gallagher, Jason C.
    Novick, Elizabeth
    Pagkalinawan, Stephen
    Lautenbach, Ebbing
    Wortmann, Glenn
    Kalayjian, Robert C.
    Eilertson, Brandon
    Farrell, John J.
    McCarty, Todd
    Hill, Carol
    Fowler, Vance G.
    Kreiswirth, Barry N.
    Bonomo, Robert A.
    van Duin, David
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (02) : 229 - 237
  • [46] Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae
    K. T. Mulroney
    J. M. Hall
    X. Huang
    E. Turnbull
    N. M. Bzdyl
    A. Chakera
    U. Naseer
    E. M. Corea
    M. J. Ellington
    K. L. Hopkins
    A. L. Wester
    O. Ekelund
    N. Woodford
    T. J. J. Inglis
    Scientific Reports, 7
  • [47] Carbapenem-Resistant Klebsiella Pneumoniae in Lung Transplantation Recipients
    Morlacchi, L.
    Rossetti, V.
    Tarsia, P.
    Travierso, C.
    Rosso, L.
    Nosotti, M.
    Blasi, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S306 - S307
  • [48] Carbapenem-resistant Klebsiella pneumoniae transmission associated to endoscopy
    Orsi, Giovanni Battista
    Venditti, Mario
    AMERICAN JOURNAL OF INFECTION CONTROL, 2013, 41 (09) : 849 - 850
  • [49] Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae
    Mulroney, K. T.
    Hall, J. M.
    Huang, X.
    Turnbull, E.
    Bzdyl, N. M.
    Chakera, A.
    Naseer, U.
    Corea, E. M.
    Ellington, M. J.
    Hopkins, K. L.
    Wester, A. L.
    Ekelund, O.
    Woodford, N.
    Inglis, T. J. J.
    SCIENTIFIC REPORTS, 2017, 7
  • [50] Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art
    Petrosillo, Nicola
    Giannella, Maddalena
    Lewis, Russell
    Viale, Pierluigi
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (02) : 159 - 177